ABCZF News and Press, Abcam PLC From 01/19/23

Summary Vir Biotechnology is a commercial-stage immunology company that bases its activity on infectious disease prevention. The agreement with GSK made it possible to obtain large revenues and profits in 2022. A good pipeline allows us to assume high growth in the coming years. ...

Abcam plc: Update on AIM Delisting PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , Dec. 12, 2022 /PRNewswire/ -- Abcam plc, (AIM: ABC) and (NASDAQ: ABCM) (" Abcam " or the " Company "), a global leader in the supply of life science research t...

ABCAM PLC: Result of General Meeting - Shareholders approve AIM Delisting PR Newswire CAMBRIDGE, England and WALTHAM, Mass. , Nov. 11, 2022 /PRNewswire/ -- Abcam plc (AIM: ABCM) (ABC: ABCM) (Nasdaq: ABCM) ("Abcam" or the "Company"), a global leader in...

Abcam plc (ABCM) Q4 2022 Results Conference Call September 12, 2022 08:00 AM Company Participants Tommy Thomas - IR Alan Hirzel - CEO Michael Baldock - CFO Conference Call Participants Tejas Savant - Morgan Stanley Charles Weston - RBC Puneet ...

Abcam: Appointment of Vice President of Investor Relations Canada NewsWire CAMBRIDGE, England , June 27, 2022 /CNW/ -- Abcam plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, tod...

Abcam plc (ABCM) Q4 2021 Earnings Conference Call March 14, 2022 09:00 A.M. ET Company Participants Alan Hirzel - CEO Michael S. Baldock - CFO James Stavely - VP, IR Conference Call Participants Puneet Souda - SVB Leerink Tejas Sevant - Morgan Stanley Stefan Hamill - Numis Matt Larew - Willia...

The following slide deck was published by Abcam plc in conjunction with their 2021 Q4 earnings call. For further details see: Abcam plc 2021 Q4 - Results - Earnings Call Presentation

Harding Loevner is an investment manager that invests primarily in publicly traded global equities. We were founded in 1989 by former managers for the Rockefeller family. Harding Loevner is a Delaware limited partnership. We operate independently of Affiliated Managers Group. The Glob...

Life sciences company Abcam (ABCZF) has inaugurated a new facility in Boston, Massachusetts. The 100,000ft2 facility will serve as a hub for Abcam's R&D and commercial activities in the region as the company approaches 20 years of operation in the U.S. The space more than doubles Abcam's ...

Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The strategy seeks to invest in a small number of industry-leading companies with sustainable competitive advantages and the opportunity to generate durab...